Targeting microRNA may benefit some ovarian and breast cancer patients

(University of Texas M. D. Anderson Cancer Center) A genetic misfire called the 3q26.2 amplicon can cause real havoc. In fact, it is among the most frequent chromosomal aberrations seen in many cancers, including ovarian and breast cancers.